Womack Financial LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,358 shares of the company’s stock, valued at approximately $689,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Barrow Hanley Mewhinney & Strauss LLC bought a new position in Merck KGaA in the second quarter worth $942,087,000. Bank of Nova Scotia purchased a new position in Merck KGaA during the second quarter valued at $281,696,000. Danske Bank A S bought a new stake in shares of Merck KGaA during the 2nd quarter valued at $276,535,000. Cullen Capital Management LLC bought a new stake in shares of Merck KGaA during the 2nd quarter valued at $259,158,000. Finally, Korea Investment CORP purchased a new stake in shares of Merck KGaA in the 2nd quarter worth about $239,191,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Up 0.1%
Shares of Merck KGaA stock opened at $163.45 on Tuesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a 50-day moving average of $162.78 and a 200 day moving average of $148.59. The firm has a market cap of $21.12 billion, a price-to-earnings ratio of 24.95 and a beta of 0.96. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
